Education and Training

Publications

1. Leuchter MK, Citrenbaum C, Wilson AC, Tibbe TD, Jackson NJ, Krantz DE, Wilke SA, Corlier J, Strouse TB, Hoftman GD, Tadayonnejad R, Koek RJ, Slan AR, Ginder ND, Distler MG, Artin H, Lee JH, Adelekun AE, Einstein EH, Oughli HA, Leuchter AF. The effect of older age on outcomes of rTMS treatment for treatment-resistant depression.. International psychogeriatrics, 2024.
2. Rohrbach EW, Knapp EM, Deshpande SA, Krantz DE. Expression and potential regulatory functions of Drosophila octopamine receptors in the female reproductive tract.. G3 (Bethesda, Md.), 2024.
3. Bonanno SL, Sanfilippo P, Eamani A, Sampson MM, Binu K, Li K, Burns GD, Makar ME, Zipursky SL, Krantz DE. Constitutive and conditional epitope-tagging of endogenous G protein coupled receptors in Drosophila.. bioRxiv : the preprint server for biology, 2023.
4. Leuchter MK, Citrenbaum C, Wilson AC, Tibbe TD, Jackson NJ, Krantz DE, Wilke SA, Corlier J, Strouse TB, Hoftman GD, Tadayonnejad R, Koek RJ, Slan AR, Ginder ND, Distler MG, Artin H, Lee JH, Adelekun AE, Leuchter AF. A comparison of self- and observer-rated scales for detecting clinical improvement during repetitive transcranial stimulation (rTMS) treatment of depression.. Psychiatry research, 2023.
5. Citrenbaum C, Corlier J, Ngo D, Vince-Cruz N, Wilson A, Wilke SA, Krantz D, Tadayonnejad R, Ginder N, Levitt J, Lee JH, Leuchter MK, Strouse TB, Corse A, Vyas P, Leuchter AF. Pretreatment pupillary reactivity is associated with differential early response to 10 Hz and intermittent theta-burst repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD).. Brain stimulation, 2023.
6. Hutton TM, Aaronson ST, Carpenter LL, Pages K, Krantz D, Lucas L, Chen B, Sackeim HA. Dosing transcranial magnetic stimulation in major depressive disorder: Relations between number of treatment sessions and effectiveness in a large patient registry.. Brain stimulation, 2023.
7. Tadayonnejad R, Citrenbaum C, Ngo TDP, Corlier J, Wilke SA, Slan A, Distler MG, Hoftman G, Adelekun AE, Leuchter MK, Koek RJ, Ginder ND, Krantz D, Artin H, Strouse T, Bari AA, Leuchter AF. Right lateral orbitofrontal cortex inhibitory transcranial magnetic stimulation for treatment of refractory mood and depression.. Brain stimulation, 2023.
8. Citrenbaum C, Corlier J, Ngo D, Vince-Cruz N, Wilson A, Wilke S, Krantz D, Tadayonnejad R, Ginder N, Levitt J, Lee JH, Strouse T, Corse A, Vyas P, Leuchter AF. Pretreatment pupillary reactivity is associated with outcome of Repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD).. Journal of affective disorders, 2023.
9. Bonanno SL, Krantz DE. Transcriptional changes in specific subsets of Drosophila neurons following inhibition of the serotonin transporter.. Translational psychiatry, 2023.
10. Asuncion JD, Eamani A, Rohrbach EW, Knapp EM, Deshpande SA, Bonanno SL, Murphy JE, Lawal HO, Krantz DE. Precise CRISPR-Cas9-mediated mutation of a membrane trafficking domain in the Drosophila vesicular monoamine transporter gene.. Current research in physiology, 2023.
11. Rohrbach EW, Knapp EM, Deshpande SA, Krantz DE. Drosophila cells that express octopamine receptors can either inhibit or promote oviposition.. bioRxiv : the preprint server for biology, 2023.
12. Bonanno SL, Krantz DE. Transcriptional changes in specific subsets of Drosophila neurons following inhibition of the serotonin transporter.. Research square, 2023.
13. Knapp EM, Kaiser A, Arnold RC, Sampson MM, Ruppert M, Xu L, Anderson MI, Bonanno SL, Scholz H, Donlea JM, Krantz DE. Mutation of the Drosophila melanogaster serotonin transporter dSERT impacts sleep, courtship, and feeding behaviors.. PLoS genetics, 2022.
14. Tadayonnejad R, Wilson AC, Chu SA, Corlier J, Citrenbaum C, Ngo TDP, Hovhannisyan E, Ginder ND, Levitt JG, Wilke SA, Krantz D, Bari AA, Leuchter AF. Use of right orbitofrontal repetitive transcranial magnetic stimulation (rTMS) augmentation for treatment-refractory obsessive-compulsive disorder with comorbid major depressive disorder.. Psychiatry research, 2022.
15. Deshpande SA, Rohrbach EW, Asuncion JD, Harrigan J, Eamani A, Schlingmann EH, Suto DJ, Lee PT, Schweizer FE, Bellen HJ, Krantz DE. Regulation of Drosophila oviduct muscle contractility by octopamine.. iScience, 2022.
16. Marder KG, Cho J, Chincanchan R, Wilson AC, Corlier J, Krantz DE, Ginder ND, Lee JC, Wilke SA, Tadayonnejad R, Levitt J, Ishiyama A, Leuchter MK, Leuchter AF. Sequential Prefrontal and Temporoparietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment of Tinnitus With and Without Comorbid Depression: A Case Series and Systematic Review.. Frontiers in neurology, 2022.
17. Leuchter MK, Rosenberg BM, Schapira G, Wong NR, Leuchter AF, McGlade AL, Krantz DE, Ginder ND, Lee JC, Wilke SA, Tadayonnejad R, Levitt J, Marder KG, Craske MG, Iacoboni M. Treatment of Spider Phobia Using Repeated Exposures and Adjunctive Repetitive Transcranial Magnetic Stimulation: A Proof-of-Concept Study.. Frontiers in psychiatry, 2022.
18. Mirman AM, Corlier J, Wilson AC, Tadayonnejad R, Marder KG, Pleman CM, Krantz DE, Wilke SA, Levitt JG, Ginder ND, Ojha R, Daskalakis ZJ, Leuchter AF, Lee JC. Absence of early mood improvement as a robust predictor of rTMS nonresponse in major depressive disorder.. Depression and anxiety, 2022.
19. Gulersen M, Bornstein E, Domney A, Blitz MJ, Rafael TJ, Li X, Krantz D, Rochelson B. Cerclage in singleton gestations with an extremely short cervix (≤10 mm) and no history of spontaneous preterm birth.. American journal of obstetrics & gynecology MFM, 2021.
20. Lee JC, Corlier J, Wilson AC, Tadayonnejad R, Marder KG, Ngo D, Krantz DE, Wilke SA, Levitt JG, Ginder ND, Leuchter AF. Subthreshold stimulation intensity is associated with greater clinical efficacy of intermittent theta-burst stimulation priming for Major Depressive Disorder.. Brain stimulation, 2021.
21. Corlier J, Tadayonnejad R, Wilson AC, Lee JC, Marder KG, Ginder ND, Wilke SA, Levitt J, Krantz D, Leuchter AF. Repetitive transcranial magnetic stimulation treatment of major depressive disorder and comorbid chronic pain: response rates and neurophysiologic biomarkers.. Psychological medicine, 2021.
22. Tadayonnejad R, Wilson AC, Corlier J, Lee JC, Ginder ND, Levitt JG, Wilke SA, Marder KG, Krantz D, Bari AA, Feusner JD, Pouratian N, Leuchter AF. Sequential multi-locus transcranial magnetic stimulation for treatment of obsessive-compulsive disorder with comorbid major depression: A case series.. Brain stimulation, 2020.
23. Lee JC, Wilson AC, Corlier J, Tadayonnejad R, Marder KG, Pleman CM, Krantz DE, Wilke SA, Levitt JG, Ginder ND, Leuchter AF. Strategies for augmentation of high-frequency left-sided repetitive transcranial magnetic stimulation treatment of major depressive disorder.. Journal of affective disorders, 2020.
24. Sampson MM, Myers Gschweng KM, Hardcastle BJ, Bonanno SL, Sizemore TR, Arnold RC, Gao F, Dacks AM, Frye MA, Krantz DE. Serotonergic modulation of visual neurons in Drosophila melanogaster.. PLoS genetics, 2020.
25. Harrigan J, Brambila DF, Meera P, Krantz DE, Schweizer FE. The environmental toxicant ziram enhances neurotransmitter release and increases neuronal excitability via the EAG family of potassium channels.. Neurobiology of disease, 2020.
26. Deshpande SA, Freyberg Z, Lawal HO, Krantz DE. Vesicular neurotransmitter transporters in Drosophila melanogaster.. Biochimica et biophysica acta. Biomembranes, 2020.
27. Corlier J, Wilson A, Hunter AM, Vince-Cruz N, Krantz D, Levitt J, Minzenberg MJ, Ginder N, Cook IA, Leuchter AF. Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive Disorder.. Cerebral cortex (New York, N.Y. : 1991), 2019.
28. Levitt JG, Kalender G, O’Neill J, Diaz JP, Cook IA, Ginder N, Krantz D, Minzenberg MJ, Vince-Cruz N, Nguyen LD, Alger JR, Leuchter AF. Dorsolateral prefrontal γ-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy. Journal of psychiatry & neuroscience : JPN, 2019.
29. Cook IA, Congdon E, Krantz DE, Hunter AM, Coppola G, Hamilton SP, Leuchter AF. Time Course of Changes in Peripheral Blood Gene Expression During Medication Treatment for Major Depressive Disorder.. Frontiers in genetics, 2019.
30. Hunter AM, Minzenberg MJ, Cook IA, Krantz DE, Levitt JG, Rotstein NM, Chawla SA, Leuchter AF. Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder.. Brain and behavior, 2019.
31. Hunter AM, Nghiem TX, Cook IA, Krantz DE, Minzenberg MJ, Leuchter AF. Change in Quantitative EEG Theta Cordance as a Potential Predictor of Repetitive Transcranial Magnetic Stimulation Clinical Outcome in Major Depressive Disorder.. Clinical EEG and neuroscience, 2017.
32. Aguilar JI, Dunn M, Mingote S, Karam CS, Farino ZJ, Sonders MS, Choi SJ, Grygoruk A, Zhang Y, Cela C, Choi BJ, Flores J, Freyberg RJ, McCabe BD, Mosharov EV, Krantz DE, Javitch JA, Sulzer D, Sames D, Rayport S, Freyberg Z. Neuronal Depolarization Drives Increased Dopamine Synaptic Vesicle Loading via VGLUT.. Neuron, 2017.
33. Kobayashi B, Cook IA, Hunter AM, Minzenberg MJ, Krantz DE, Leuchter AF. Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder?. International review of psychiatry (Abingdon, England), 2017.
34. Freyberg Z, Sonders MS, Aguilar JI, Hiranita T, Karam CS, Flores J, Pizzo AB, Zhang Y, Farino ZJ, Chen A, Martin CA, Kopajtic TA, Fei H, Hu G, Lin YY, Mosharov EV, McCabe BD, Freyberg R, Wimalasena K, Hsin LW, Sames D, Krantz DE, Katz JL, Sulzer D, Javitch JA. Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain.. Nature communications, 2016.
35. Martin CA, Myers KM, Chen A, Martin NT, Barajas A, Schweizer FE, Krantz DE. Ziram, a pesticide associated with increased risk for Parkinson's disease, differentially affects the presynaptic function of aminergic and glutamatergic nerve terminals at the Drosophila neuromuscular junction.. Experimental neurology, 2015.
36. Majdi S, Berglund EC, Dunevall J, Oleinick AI, Amatore C, Krantz DE, Ewing AG. Electrochemical Measurements of Optogenetically Stimulated Quantal Amine Release from Single Nerve Cell Varicosities in Drosophila Larvae.. Angewandte Chemie (International ed. in English), 2015.
37. Leuchter AF, Hunter AM, Krantz DE, Cook IA. Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments.. Annals of the New York Academy of Sciences, 2015.
38. Wasserman SM, Aptekar JW, Lu P, Nguyen J, Wang AL, Keles MF, Grygoruk A, Krantz DE, Larsen C, Frye MA. Olfactory neuromodulation of motion vision circuitry in Drosophila.. Current biology : CB, 2015.
39. Leuchter AF, Hunter AM, Krantz DE, Cook IA. Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder.. Dialogues in clinical neuroscience, 2014.
40. Martin CA, Barajas A, Lawless G, Lawal HO, Assani K, Lumintang YP, Nunez V, Krantz DE. Synergistic effects on dopamine cell death in a Drosophila model of chronic toxin exposure.. Neurotoxicology, 2014.
41. Grygoruk A, Chen A, Martin CA, Lawal HO, Fei H, Gutierrez G, Biedermann T, Najibi R, Hadi R, Chouhan AK, Murphy NP, Schweizer FE, Macleod GT, Maidment NT, Krantz DE. The redistribution of Drosophila vesicular monoamine transporter mutants from synaptic vesicles to large dense-core vesicles impairs amine-dependent behaviors.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014.
42. Martin CA, Krantz DE. Drosophila melanogaster as a genetic model system to study neurotransmitter transporters.. Neurochemistry international, 2014.
43. Lawal HO, Krantz DE. SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine.. Molecular aspects of medicine, 2013.
44. Wu TH, Lu YN, Chuang CL, Wu CL, Chiang AS, Krantz DE, Chang HY. Loss of vesicular dopamine release precedes tauopathy in degenerative dopaminergic neurons in a Drosophila model expressing human tau.. Acta neuropathologica, 2013.
45. Chen A, Ng F, Lebestky T, Grygoruk A, Djapri C, Lawal HO, Zaveri HA, Mehanzel F, Najibi R, Seidman G, Murphy NP, Kelly RL, Ackerson LC, Maidment NT, Jackson FR, Krantz DE. Dispensable, redundant, complementary, and cooperative roles of dopamine, octopamine, and serotonin in Drosophila melanogaster.. Genetics, 2012.
46. Simon AF, Chou MT, Salazar ED, Nicholson T, Saini N, Metchev S, Krantz DE. A simple assay to study social behavior in Drosophila: measurement of social space within a group.. Genes, brain, and behavior, 2011.
47. Brooks ES, Greer CL, Romero-Calderón R, Serway CN, Grygoruk A, Haimovitz JM, Nguyen BT, Najibi R, Tabone CJ, de Belle JS, Krantz DE. A putative vesicular transporter expressed in Drosophila mushroom bodies that mediates sexual behavior may define a neurotransmitter system.. Neuron, 2011.
48. Grygoruk A, Fei H, Daniels RW, Miller BR, Chen A, DiAntonio A, Krantz DE. Vesicular neurotransmitter transporter trafficking in vivo: moving from cells to flies.. Fly, 2010.
49. Lawal HO, Chang HY, Terrell AN, Brooks ES, Pulido D, Simon AF, Krantz DE. The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons.. Neurobiology of disease, 2010.
50. Fei H, Chow DM, Chen A, Romero-Calderón R, Ong WS, Ackerson LC, Maidment NT, Simpson JH, Frye MA, Krantz DE. Mutation of the Drosophila vesicular GABA transporter disrupts visual figure detection.. The Journal of experimental biology, 2010.
51. Bahadorani S, Cho J, Lo T, Contreras H, Lawal HO, Krantz DE, Bradley TJ, Walker DW. Neuronal expression of a single-subunit yeast NADH-ubiquinone oxidoreductase (Ndi1) extends Drosophila lifespan.. Aging cell, 2010.
52. Grygoruk A, Fei H, Daniels RW, Miller BR, Diantonio A, Krantz DE. A tyrosine-based motif localizes a Drosophila vesicular transporter to synaptic vesicles in vivo.. The Journal of biological chemistry, 2010.
53. Cheli VT, Daniels RW, Godoy R, Hoyle DJ, Kandachar V, Starcevic M, Martinez-Agosto JA, Poole S, DiAntonio A, Lloyd VK, Chang HC, Krantz DE, Dell'Angelica EC. Genetic modifiers of abnormal organelle biogenesis in a Drosophila model of BLOC-1 deficiency.. Human molecular genetics, 2009.
54. Mosharov EV, Larsen KE, Kanter E, Phillips KA, Wilson K, Schmitz Y, Krantz DE, Kobayashi K, Edwards RH, Sulzer D. Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons.. Neuron, 2009.
55. Simon AF, Daniels R, Romero-Calderón R, Grygoruk A, Chang HY, Najibi R, Shamouelian D, Salazar E, Solomon M, Ackerson LC, Maidment NT, Diantonio A, Krantz DE. Drosophila vesicular monoamine transporter mutants can adapt to reduced or eliminated vesicular stores of dopamine and serotonin.. Genetics, 2008.
56. Romero-Calderón R, Uhlenbrock G, Borycz J, Simon AF, Grygoruk A, Yee SK, Shyer A, Ackerson LC, Maidment NT, Meinertzhagen IA, Hovemann BT, Krantz DE. A glial variant of the vesicular monoamine transporter is required to store histamine in the Drosophila visual system.. PLoS genetics, 2008.
57. Fei H, Grygoruk A, Brooks ES, Chen A, Krantz DE. Trafficking of vesicular neurotransmitter transporters.. Traffic (Copenhagen, Denmark), 2008.
58. Norton ME, Hopkins LM, Pena S, Krantz D, Caughey AB. First-trimester combined screening: experience with an instant results approach.. American journal of obstetrics and gynecology, 2007.
59. Simon AF, Krantz DE. Road rage and fruit flies.. Nature genetics, 2007.
60. Romero-Calderón R, Shome RM, Simon AF, Daniels RW, DiAntonio A, Krantz DE. A screen for neurotransmitter transporters expressed in the visual system of Drosophila melanogaster identifies three novel genes.. Developmental neurobiology, 2007.
61. Fei H, Karnezis T, Reimer RJ, Krantz DE. Membrane topology of the Drosophila vesicular glutamate transporter.. Journal of neurochemistry, 2007.
62. Sang TK, Chang HY, Lawless GM, Ratnaparkhi A, Mee L, Ackerson LC, Maidment NT, Krantz DE, Jackson GR. A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007.
63. Falcón-Pérez JM, Romero-Calderón R, Brooks ES, Krantz DE, Dell'Angelica EC. The Drosophila pigmentation gene pink (p) encodes a homologue of human Hermansky-Pudlak syndrome 5 (HPS5).. Traffic (Copenhagen, Denmark), 2006.
64. Simon AF, Liang DT, Krantz DE. Differential decline in behavioral performance of Drosophila melanogaster with age.. Mechanisms of ageing and development, 2006.
65. Park SK, George R, Cai Y, Chang HY, Krantz DE, Friggi-Grelin F, Birman S, Hirsh J. Cell-type-specific limitation on in vivo serotonin storage following ectopic expression of the Drosophila serotonin transporter, dSERT.. Journal of neurobiology, 2006.
66. Romero-Calderón R, Krantz DE. Transport of polyamines in Drosophila S2 cells: kinetics, pharmacology and dependence on the plasma membrane proton gradient.. The Biochemical journal, 2006.
67. Krantz DE. Vesicular monogamy?. Neuron, 2006.
68. Chang HY, Grygoruk A, Brooks ES, Ackerson LC, Maidment NT, Bainton RJ, Krantz DE. Overexpression of the Drosophila vesicular monoamine transporter increases motor activity and courtship but decreases the behavioral response to cocaine.. Molecular psychiatry, 2006.
69. Greer CL, Grygoruk A, Patton DE, Ley B, Romero-Calderon R, Chang HY, Houshyar R, Bainton RJ, Diantonio A, Krantz DE. A splice variant of the Drosophila vesicular monoamine transporter contains a conserved trafficking domain and functions in the storage of dopamine, serotonin, and octopamine.. Journal of neurobiology, 2005.
70. Daniels RW, Collins CA, Gelfand MV, Dant J, Brooks ES, Krantz DE, DiAntonio A. Increased expression of the Drosophila vesicular glutamate transporter leads to excess glutamate release and a compensatory decrease in quantal content.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004.
71. Platt LD, Greene N, Johnson A, Zachary J, Thom E, Krantz D, Simpson JL, Silver RK, Snijders RJ, Goetzl L, Pergament E, Filkins K, Mahoney MJ, Hogge WA, Wilson RD, Mohide P, Hershey D, MacGregor S, Bahado-Singh R, Jackson LG, Wapner R, First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Grou. Sequential pathways of testing after first-trimester screening for trisomy 21.. Obstetrics and gynecology, 2004.
72. Krantz DE. Nerve terminals contacting a monoaminergic neuron.. Molecular psychiatry, 2001.
73. Waites CL, Mehta A, Tan PK, Thomas G, Edwards RH, Krantz DE. An acidic motif retains vesicular monoamine transporter 2 on large dense core vesicles.. The Journal of cell biology, 2001.
74. Sulzer D, Bogulavsky J, Larsen KE, Behr G, Karatekin E, Kleinman MH, Turro N, Krantz D, Edwards RH, Greene LA, Zecca L. Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.. Proceedings of the National Academy of Sciences of the United States of America, 2000.
75. Pothos EN, Larsen KE, Krantz DE, Liu Y, Haycock JW, Setlik W, Gershon MD, Edwards RH, Sulzer D. Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2000.
76. Krantz DE, Waites C, Oorschot V, Liu Y, Wilson RI, Tan PK, Klumperman J, Edwards RH. A phosphorylation site regulates sorting of the vesicular acetylcholine transporter to dense core vesicles.. The Journal of cell biology, 2000.
77. Liu Y, Krantz DE, Waites C, Edwards RH. Membrane trafficking of neurotransmitter transporters in the regulation of synaptic transmission.. Trends in cell biology, 1999.
78. Tan PK, Waites C, Liu Y, Krantz DE, Edwards RH. A leucine-based motif mediates the endocytosis of vesicular monoamine and acetylcholine transporters.. The Journal of biological chemistry, 1998.
79. Krantz DE, Peter D, Liu Y, Edwards RH. Phosphorylation of a vesicular monoamine transporter by casein kinase II.. The Journal of biological chemistry, 1997.
80. Liu Y, Peter D, Merickel A, Krantz D, Finn JP, Edwards RH. A molecular analysis of vesicular amine transport.. Behavioural brain research, 1996.
81. Liu Y, Waites C, Krantz D, Tan P, Edwards RH. Molecular analysis of neurotransmitter transport into secretory vesicles.. Cold Spring Harbor symposia on quantitative biology, 1996.
82. Krantz DD, Zidovetzki R, Kagan BL, Zipursky SL. Amphipathic beta structure of a leucine-rich repeat peptide.. The Journal of biological chemistry, 1991.
83. Krantz DE, Zipursky SL. Drosophila chaoptin, a member of the leucine-rich repeat family, is a photoreceptor cell-specific adhesion molecule.. The EMBO journal, 1990.
84. Van Vactor D, Krantz DE, Reinke R, Zipursky SL. Analysis of mutants in chaoptin, a photoreceptor cell-specific glycoprotein in Drosophila, reveals its role in cellular morphogenesis.. Cell, 1988.
85. Reinke R, Krantz DE, Yen D, Zipursky SL. Chaoptin, a cell surface glycoprotein required for Drosophila photoreceptor cell morphogenesis, contains a repeat motif found in yeast and human.. Cell, 1988.
86. Krantz DE, Brown WA. Dexamethasone suppresses beta-endorphin in humans.. Psychoneuroendocrinology, 1985.